Mevrometostat
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Mevrometostat, covering 2025-04-24 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. [Phase 3]